Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 2;14(1):2775.
doi: 10.1038/s41598-024-53229-3.

Joint effect of BMI and metabolic status on mortality among adults: a population-based longitudinal study in United States

Affiliations

Joint effect of BMI and metabolic status on mortality among adults: a population-based longitudinal study in United States

Feilong Chen et al. Sci Rep. .

Abstract

We explored the joint effects of different metabolic obesity phenotypes on all-cause and disease-specific mortality risk among the American population. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. Mortality outcome data were from mortality files linked to National Death Index record and follow-up information was up to December 31, 2019. 50,013 participants were finally included. Four metabolic obesity phenotypes were defined based on obesity and metabolic status: metabolically healthy obese (MHO), metabolically unhealthy obese (MUO), metabolically healthy non-obese (MHNO), and metabolically unhealthy non-obese (MUNO). Population-weighted Cox proportional hazards models were used to explore the all-cause and disease-specific mortality risk of metabolic obesity phenotypes. The all-cause mortality risk of MUO and MUNO was significantly higher than MHNO. MUNO was associated with a significantly increased risk of death from heart disease (HR: 1.40, 95% CI 1.16-1.70), hypertension (HR: 1.68, 95% CI 1.34-2.12), diabetes (HR: 2.29, 95% CI 1.67-3.15), and malignant neoplasms (HR:1.29, 95% CI 1.09-1.53). Metabolic unhealth significantly increased the risk of all-cause mortality, regardless of obesity status. Among individuals with metabolic unhealthy status, obesity significantly reduced the risk of all-cause mortality (HR: 0.91, 95% CI 0.85-0.98). Our study highlights the importance of identifying and characterizing metabolic obesity phenotypes in obese and metabolically abnormal patients, as well as healthy adults. Comprehensive evaluation of obesity and metabolic status is necessary to adopt appropriate interventions and treatment measures and maximize patient benefit.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
K-M survival curves of different metabolic obesity phenotypes.
Figure 2
Figure 2
Death risk of metabolic obesity phenotypes stratified by metabolic syndrome and obesity categories. MH metabolically healthy, MU metabolically unhealthy, NO non-obesity, O obesity, MetS metabolic syndrome. HRs were calculated based on weighted cox regression model after adjusting for age, gender, race, smoking status, drinking habit, socioeconomic status and education level. p for interaction was calculated based on Wald test. All-cause mortality, p for interaction = 0.025; Heart disease mortality, p for interaction = 0.644; Hypertension mortality, p for interaction = 0.984; Diabetes mortality, p for interaction = 0.601; Cancer mortality, p for interaction = 0.257. *Statistically significant.
Figure 3
Figure 3
Flow chart of participants selection.

References

    1. WHO. Obesity and overweight (2015).
    1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–2291. doi: 10.1001/jama.2016.6458. - DOI - PMC - PubMed
    1. Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384:45–52. doi: 10.1016/S0140-6736(14)60648-6. - DOI - PubMed
    1. Blüher M. Metabolically healthy obesity. Endocr. Rev. 2020 doi: 10.1210/endrev/bnaa004. - DOI - PMC - PubMed
    1. Elagizi A, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog. Cardiovasc. Dis. 2018;61:142–150. doi: 10.1016/j.pcad.2018.07.003. - DOI - PubMed